Skip to content
AnalystLens

Docusign Quarterly Report for Q1 Ended Apr 30, 2026

Filing Date
Filed June 5, 2026
Period End
April 30, 2026
Security
DOCU
One revenue dollarkept$0.09
In the record · 2018–202610-K810-Q268-K81

DOCU filed 8 annual reports (10-K), 26 quarterly reports (10-Q) and 81 current reports (8-K) between 2018 and 2026.

  1. Leadership change8-K · Dec ’18Dec ’18
  2. Material agreement8-K · Jan ’21Jan ’21
  3. Restructuring8-K · Sep ’22Sep ’22
  4. Leadership change8-K · Sep ’25Sep ’25

Summary

Summary of the 10-Q filed June 5, 2026. Cited figures are marked; the original filing is the authoritative source.

Docusign, Inc. reported revenue of $830.2 milliona for the three months ended April 30, 2026, up from $763.7 million a year earlier, with the filing attributing the increase primarily to expansion in commercial and enterprise accounts and the digital channel.

Income from operations rose to $111.3 millionb from $60.3 million, and net income was $78.2 million, or $0.40 per diluted share, compared with $72.1 million, or $0.34 per diluted share, in the prior-year quarter. Net income was held back by a $39.6 million income tax provision, which the filing attributes to higher profit before taxes, the One Big Beautiful Bill Act, and higher tax expense related to stock-based compensation. Net cash provided by operating activities was $321.7 million, and non-GAAP free cash flow was $289.4 million.

The company repurchased 6.8 million shares for $318.4 millionc during the quarter under its stock repurchase program. In March 2026, the board increased the total authorization to $4.5 billion, leaving up to $2.4 billion remaining as of April 30, 2026. Cash, cash equivalents, restricted cash and investments totaled $1.0 billion, and the $750.0 million secured revolving credit facility had no outstanding borrowings.

Total stockholders' equity declined to $1.82 billiond from $1.92 billion at January 31, 2026, largely reflecting the buybacks and an accumulated deficit that grew to $2.10 billion. The filing reports that IAM represented 12.6% of total ARR as of April 30, 2026, up from 10.8% at January 31, 2026. Remaining performance obligations for contracts greater than one year were $2.3 billion, with 58% expected to be recognized within the next 12 months.

The securities class action, Weston v. Docusign, was dismissed on January 26, 2026, and the matter is now closed, though two opt-out cases remain subject to voluntary dismissal.

Key Highlights

  1. Revenue rose to $830.2 million from $763.7 million, up 9% year over year, driven by commercial and enterprise accounts and the digital channel.
  2. Net income was $78.2 million ($0.40 diluted EPS) versus $72.1 million ($0.34 diluted EPS), while income from operations increased to $111.3 million from $60.3 million.
  3. The income tax provision rose to $39.6 million from $1.7 million, attributed to higher pre-tax profit, OBBBA-related changes, and higher stock-based compensation tax expense.
  4. Operating cash flow was $321.7 million and non-GAAP free cash flow was $289.4 million for the quarter.
  5. Share repurchases totaled $318.4 million (6.8 million shares); total authorization was raised to $4.5 billion in March 2026, with up to $2.4 billion remaining.
  6. IAM accounted for 12.6% of total ARR as of April 30, 2026, up from 10.8% at January 31, 2026.
  7. The $750.0 million revolving credit facility remained undrawn, and the securities class action Weston v. Docusign was dismissed in January 2026 with the matter closed.

Follow one dollar

Of each $1.00 of revenue in Q1 FY2027, Docusign kept $0.09.

  1. Revenue$830.2M100.0%
  2. Cost of revenue−$171.3M20.6%
  3. Gross profit$659.0M79.4%
  4. Operating costs−$547.7M66.0%
  5. Operating income$111.3M13.4%
  6. Interest, other & tax−$33.1M4.0%
  7. Net income$78.2M9.4%
Computed from 10-QQ1 FY2027filed June 5, 2026Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

Q1 FY2027 against Q1 FY2026

Line itemQ1 FY2027Q1 FY2026Change
Revenue$830.24M$763.65M+8.7%
Cost of Revenue$171.27M$157.27M+8.9%
Gross Profit$658.97M$606.38M+8.7%
R&D Expenses$159.59M$159.45M+0.1%
Operating Expenses$547.66M$546.13M+0.3%
Operating Income$111.31M$60.26M+84.7%
Net Income$78.20M$72.09M+8.5%
EPS (Basic)$0.40$0.35+14.3%
EPS (Diluted)$0.40$0.34+17.6%
Shares Outstanding (Basic)195.49M203.28M−3.8%
Shares Outstanding (Diluted)196.48M212.81M−7.7%

Frequently Asked Questions

  1. How did Docusign's profitability change in the first quarter of fiscal 2027?

    Income from operations increased to $111.3 million from $60.3 million, and net income rose to $78.2 million from $72.1 million. Gross margin was 79% in both periods, while the provision for income taxes increased to $39.6 million from $1.7 million.

  2. What drove the increase in tax expense?

    The filing attributes the increase primarily to higher profit before taxes, a higher forecasted annual effective tax rate driven by the One Big Beautiful Bill Act enacted in the second quarter of fiscal 2026, and higher tax expense related to stock-based compensation.

  3. How much cash and capital does Docusign have available, and how is it being used?

    As of April 30, 2026, cash, cash equivalents, restricted cash and investments totaled $1.0 billion, and the company had no borrowings under its $750.0 million revolving credit facility. During the quarter it repurchased 6.8 million shares for $318.4 million, with up to $2.4 billion remaining under its repurchase authorization.

  4. What is the status of Docusign's securities litigation?

    The Weston v. Docusign securities class action was dismissed on January 26, 2026, with judgment entered for the company, and plaintiffs did not appeal. Two opt-out cases filed in June 2025 were stayed and then lifted on May 6, 2026, and the company is pursuing their voluntary dismissal.

  5. What do the backlog and recurring revenue metrics indicate?

    Remaining performance obligations for contracts greater than one year were $2.3 billion, with 58% expected to be recognized in the next 12 months. IAM represented 12.6% of total ARR as of April 30, 2026, compared with 10.8% at January 31, 2026.